Advertisement Agilent, Ameritox sign research deal to advance medication monitoring - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Agilent, Ameritox sign research deal to advance medication monitoring

Agilent Technologies and Ameritox have entered into a research collaboration deal to advance analysis of medication monitoring.

Agilent’s commercial products include RapidFire system, designed for use in pharmaceutical and biopharmaceutical laboratories.

Agilent RapidFire business director Can Ozbal said, "By using multiple RapidFire systems Ameritox is streamlining the analysis of small panels of exogenous compounds compared to traditional methods of analysis."

Ameritox chief laboratory officer Jay Zimmerman said, "By working together and sharing moment-by-moment laboratory activity, this research arrangement gives both Ameritox and Agilent a vantage point from which we can continue to discover new uses for our science and technology."

Agilent provides various technology services in chemical analysis, life sciences, diagnostics, electronics and communications.